Adolescent Health in Myanmar
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Eliminating hepatitis C virus (HCV) in Australia is now a possibility, with the listing of direct-acting antiviral (DAA) drugs on the PBS. But this is one step in the path towards elimination.
Burnet will also make a major contribution in global efforts to eliminate hepatitis B & C as major health threats. This includes supporting vital research underway by our researchers to create a novel, effective, low-cost HCV vaccine suitable for resource-constrained countries.
Burnet Institute’s Eliminate Viral Hepatitis strategy is focussed on:
Working together, with research organisations, governments, the community and affected populations, Burnet will help change the course of hepatitis C infection and its impact as a public health threat.
Hepatitis C virus (HCV) affects more than 250,000 Australians resulting in up to 630 deaths from liver cancer and liver failure each year. Globally, more than 500,000 people die from HCV-related causes.
The ambitious journey to eliminate viral hepatitis has begun.
Deputy Director (Programs); Adjunct Professor, Monash University, DEPM.
22 December, 2020
As the world grappled with emerging pandemic, Burnet made another important discovery about bats and viruses.
30 October, 2020
Scroll through Burnet’s latest stories in an all-new digital interface in this special COVID-19 edition of IMPACT.